Sharps Compliance - SMED Stock Forecast, Price & News

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System to treat used needles, syringes, and other used healthcare products; Route-Based Pickup Service, a medical and hazardous waste pick-up services; and MedSafe, a solution for the safe collection, transportation, and disposal of unwanted and expired ultimate-user medications. The company also provides TakeAway Medication Recovery System that facilitates the proper disposal of unused medications; Black Pail Program for Rx, a solution with minimal segregation for the disposal of various pharmaceuticals; Inhaler Disposal to collect, transport, and destroy used pharmaceutical inhalers; Hazardous Drug Spill Control Kit for the cleanup of chemotherapy and other HD spills; TakeAway Recycle System for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; ComplianceTRAC, a Web-based compliance and training program; and Universal Waste Shipback Systems to collect, transport, and recycle light bulbs, batteries, and other mercury containing devices. In addition, it offers other solutions, such as TakeAway Environmental Return System, SharpsTracer, Sharps Secure, Needle Disposal System, Complete Needle Collection and Disposal System, Pitch-It IV Poles, Asset Return System, and Spill Kit Recovery System, as well as Sharps MWMS, a medical waste management system. The company serves customers in home health care, retail clinics and immunizing pharmacies, pharmaceutical manufacturers, professional offices, assisted living and long-term care facilities, and government agencies, as well as distributors. Sharps Compliance Corp. was founded in 1992 and is headquartered in Houston, Texas.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SMED. StockNews.com lowered shares of Sharps Compliance from a "hold" rating to a "sell" rating in a research report on Wednesday, July 13th. Lake Street Capital cut shares of Sharps Compliance from a "buy" rating to a "hold" rating in a report on Tuesday, July 12th. Barrington Research downgraded shares of Sharps Compliance from an "outperform" rating to a "market perform" rating in a research note on Tuesday, July 12th. Finally, Stifel Nicolaus cut Sharps Compliance from a "buy" rating to a "hold" rating in a research report on Wednesday, July 13th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. Based on data from MarketBeat.com, Sharps Compliance has a consensus rating of "Hold" and a consensus price target of $6.50.

Sharps Compliance Price Performance

SMED Stock traded up $0.03 on Friday, reaching $8.70. 77,430 shares of the company's stock were exchanged, compared to its average volume of 234,187. Sharps Compliance has a twelve month low of $2.83 and a twelve month high of $9.99. The company has a quick ratio of 3.03, a current ratio of 3.50 and a debt-to-equity ratio of 0.06. The stock has a fifty day moving average of $5.72 and a 200-day moving average of $5.47. The firm has a market cap of $169.04 million, a PE ratio of 27.97 and a beta of 1.28.

Sharps Compliance (NASDAQ:SMED - Get Rating) last announced its quarterly earnings results on Wednesday, May 11th. The industrial products company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). Sharps Compliance had a net margin of 7.88% and a return on equity of 5.48%. The company had revenue of $17.58 million during the quarter, compared to analysts' expectations of $16.67 million. During the same quarter in the prior year, the business earned $0.40 EPS. As a group, equities analysts predict that Sharps Compliance will post -0.03 EPS for the current fiscal year.

Insider Activity

In related news, CEO David P. Tusa sold 25,000 shares of the firm's stock in a transaction that occurred on Friday, May 27th. The stock was sold at an average price of $4.25, for a total value of $106,250.00. Following the completion of the transaction, the chief executive officer now directly owns 88,088 shares of the company's stock, valued at approximately $374,374. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Sharps Compliance news, CEO David P. Tusa sold 25,000 shares of the company's stock in a transaction dated Friday, May 27th. The shares were sold at an average price of $4.25, for a total value of $106,250.00. Following the sale, the chief executive officer now owns 88,088 shares of the company's stock, valued at $374,374. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David P. Tusa sold 88,988 shares of the firm's stock in a transaction that occurred on Thursday, June 2nd. The stock was sold at an average price of $4.41, for a total transaction of $392,437.08. Following the transaction, the chief executive officer now directly owns 56,094 shares of the company's stock, valued at $247,374.54. The disclosure for this sale can be found here. In the last three months, insiders sold 147,294 shares of company stock worth $640,904. Company insiders own 4.80% of the company's stock.